WHO Intellectual Property and Traditional Medicines Project
WHO
European Commission October 5, 1998 note memorandum on the WHO Revised Drug Strategy negotiation
European Commission (DG 1) note on the WHO’s Revised Drug Strategy EUROPEAN COMMISSION DIRECTORATE GENERAL 1 EXTERNAL RELATIONS: COMMERCIAL POLICY AND RELATIONS WITH NORTH AMERICA. THE FAR EAST, AUSTRALIA AND NEW ZEALAND Directorate D -Sectoral trade questions,… Continue Reading
WHO Pandemic agreement text as of Saturday, 12 April 2025 at 09:05
This is the pandemic agreement text, as of today. Negotiations are resumed Tuesday, but this is what people expect to be in the fine agreement. Green is supposed to mean the text is final. The EU still not in agreement… Continue Reading
Proposal for Addition Of Risdiplam to WHO Model List Of Essential Medicines, for the treatment of Spinal Muscular Atrophy (SMA).
On November 1, 2024, Knowledge Ecology International (KEI) submitted a proposal for the addition of risdiplam to the World Health Organization’s (WHO) Model List of Essential Medicine (EML). You can access the full proposal here: risdiplam2WHOEML1Nov2024 The EML, updated every… Continue Reading
KEI Comments on the May 10, 2024 INB Draft of the Pandemic Accord
On May 15, 2024, Health Policy Watch published the latest draft (as of May 10, 2024) of the WHO Pandemic Accord by the Intergovernmental Negotiating Body (INB). In order to provide a better understanding of what is and is not… Continue Reading
Letter to Anne Yu, Director for Global Pandemic Preparedness, NSC, on negotiations for WHO pandemic agreement
This was sent via email today. Jamie ————— May 1, 2024 Anne Yu Director for Global Pandemic Preparedness Development, Global Health and Humanitarian Response, National Security Council Staff, Executive Office of the President Dear Anne Yu, I’m guessing you are… Continue Reading
KEI comments on six references to “mutually agreed terms” in the WHO pandemic agreement negotiating text: A/INB/9/3 Rev.1, 22 April 2024
PDF version is available here: KEI.MutuallyAgreedTerms.A_INB_9_3Rev1.22April2024draft KEI comments on six references to “mutually agreed terms” in the WHO pandemic agreement negotiating text: A/INB/9/3 Rev.1, 22 April 2024 James Love Knowledge Ecology International April 28, 2024, revised April 29, 2024 Introduction… Continue Reading
Brackets on March 23, 2024 INB text on Chapter 11
To get an idea of the challenges of getting agreement on the WHO pandemic accord text, consider the state of just one article on Saturday, March 23, 2024. Article 11 has 6 paragraphs on technology transfer. According to an analysis… Continue Reading
KEI Comments on the Implications of Access and Benefit Sharing Commitments/Regimes and Other Proposed Commitments in the WHO Pandemic Agreement
On January 29, 2024, KEI submitted comments in response the Federal Register notice posted by the Department of Health and Human Services (HHS) concerning, “the Implications of Access and Benefit Sharing (ABS) Commitments/Regimes and Other Proposed Commitments Being Considered Under… Continue Reading
WHO Working Group on Amendments to the International Health Regulations
KEI statement to the Working Group on Amendments to the International Health Regulations December 7, 2023 KEI agrees with others that the IHR regulations should incorporate measures to address equitable access to products. KEI reminds delegations that in 2019, the… Continue Reading